Frontiers | Mutation-Derived Neoantigens for Cancer Immunotherapy
Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines | PNAS
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients | Scientific Reports
TP53 alterations of hormone-naïve prostate cancer in the Chinese population | Prostate Cancer and Prostatic Diseases
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine
Clinical implications of subclonal TP53 mutations in acute myeloid leukemia | Haematologica
Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells | Breast Cancer Research | Full Text
IJMS | Free Full-Text | Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors | HTML
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - ScienceDirect
Mutant p53 elicits context-dependent pro-tumorigenic phenotypes | Oncogene
TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma
Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function | PNAS
Frontiers | Prevalence of the Brazilian TP53 Founder c.1010G>A (p.Arg337His) in Lung Adenocarcinoma: Is Genotyping Warranted in All Brazilian Patients?
The cancer-associated, gain-of-function TP53 variant P152Lp53 activates multiple signaling pathways implicated in tumorigenesis - Journal of Biological Chemistry
Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others | Nature Reviews Clinical Oncology
Five‐year overall survival rate in patients with oncomorphic and... | Download Scientific Diagram
TP53 mutations as potential prognostic markers for specific cancers: Analysis of data from The Cancer Genome Atlas and the International Agency for Research on Cancer TP53 Database | bioRxiv
Concurrent TP53 Mutations Facilitate Resistance Evolution in EGFR-Mutant Lung Adenocarcinoma - Journal of Thoracic Oncology
Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm | ACS Chemical Biology
Systematic identification of mutations and copy number alterations associated with cancer patient prognosis | eLife
Mutations in TP53 and other heterogeneous genes help to distinguish metastases from new primary malignancies | medRxiv
TP53 mutation spectrum in primary colorectal cancers. a Proportion of... | Download Scientific Diagram
High prevalence and allele burden-independent prognostic importance of p53 mutations in an inner-city MDS/AML cohort | Leukemia
IJMS | Free Full-Text | Do Mutations Turn p53 into an Oncogene? | HTML
Disarming mutant p53 oncogenic function - ScienceDirect
Targeting the Prion-like Aggregation of Mutant p53 to Combat Cancer | Accounts of Chemical Research
